Mint Tower Capital Management B.V. Intercept Pharmaceuticals, Inc. Transaction History
Mint Tower Capital Management B.V.
- $314 Million
- Q2 2024
A detailed history of Mint Tower Capital Management B.V. transactions in Intercept Pharmaceuticals, Inc. stock. As of the latest transaction made, Mint Tower Capital Management B.V. holds 15,000 shares of ICPT stock, worth $0. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$0% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ICPT
# of Institutions
6Shares Held
1.04MCall Options Held
30KPut Options Held
5.9KAbout INTERCEPT PHARMACEUTICALS, INC.
- Ticker ICPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,127,400
- Description
- Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...